Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Trastuzumab |
Trade Name | Herceptin |
Synonyms | Anti HER2 |
Drug Descriptions |
Herceptin (trastuzumab) is a monoclonal antibody, which binds ERBB2 (HER2) to induce tumor cellular cytotoxicity (PMID: 17611206). Herceptin (trastuzumab) is FDA approved for HER2-overexpressing (or amplification) breast cancer, gastric adenocarcinoma, and gastroesophageal junction adenocarcinoma (FDA.gov). |
DrugClasses | HER2 (ERBB2) Antibody 76 |
CAS Registry Number | 180288-69-1 |
NCIT ID | C1647 |